For the first time, scientists of the university of Georgetown (US), found biomarkers for Alzheimer’s Disease (AD) in blood samples, which were present before any visible symptoms of AD were visible. Last weekend, they published their results in Nature Medicine. These biomarkers could detect AD two to three years before any detectable memory or function loss. MedZine spoke about this development to prof. dr. Philip Scheltens, who is a professor in cognitive neurology and director of the Alzheimer Center at the VU medical center in Amsterdam, and dr. ir. Charlotte Teunissen, who is head of the neurochemistry laboratory at the VU medical center in Amsterdam and an expert on AD biomarkers. Continue reading
Showing articles tagged with 'Vu'